Mirum Pharmaceuticals, Inc. · 1 day ago
Senior Director, Intellectual Property Attorney
Foster City, CA
Full-time
Onsite
Director/Executive
$315K/yr - $335K/yr
12+ years expMirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. They are seeking an experienced Senior Director, Intellectual Property to lead their intellectual property strategy and execute a comprehensive global IP program in support of their mission.
BiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
In partnership with the Chief Legal Officer and outside intellectual property counsel, develop and oversee a global IP strategy for the company’s patents, trademarks and trade secrets
Lead and oversee the drafting, filing, prosecution, and maintenance of a worldwide patent portfolio
Provide guidance on patent term extensions and regulatory exclusivities
Deliver freedom-to-operate (FTO), patent validity, and infringement analyses to inform decision-making across development and commercial programs
Manage the company’s global trademark portfolio
Provide IP guidance in business development, licensing, collaboration, and M&A transactions; lead or support IP due diligence efforts
In collaboration with other Legal team members, draft and negotiate IP provisions in material agreements (e.g., research collaboration, license, clinical, supply, manufacturing and distribution agreements)
With the Chief Legal Officer and outside counsel, manage potential Hatch-Waxman patent litigation
Direct and manage patent dispute processes such as U.S. inter partes review (IPR), post-grant proceedings, European oppositions, and other adversarial actions in key jurisdictions
Support pre-litigation risk assessments
Partner with program teams and internal functions to identify and capture inventions at an early stage
Evaluate inventions and determine whether patent or trade secret protection would be appropriate
Support product launches with lifecycle management strategies
With the Chief Legal Officer, manage outside counsel relationships with a focus on cost-effectiveness and quality
Deliver timely, practical, and business-focused legal advice across jurisdictions
Qualification
Required
J.D. and licensed to practice law in at least one U.S. jurisdiction (active and in good standing)
USPTO registration and eligibility to practice patent law
12+ years of intellectual property law experience, with significant in-house and/or law firm experience in the biopharmaceutical sector
Advanced scientific degree (M.S. or Ph.D.) in chemistry, biochemistry or related discipline
Strong global perspective, with experience managing patent portfolios across the U.S., EU, UK and Japan
Proven track record advising executives and program teams, balancing legal risk with business goals
Excellent written and oral communication skills — able to translate complex IP concepts for diverse stakeholders
Preferred
Experience with rare disease regulatory frameworks, including orphan drug exclusivity in the U.S. and EU
Demonstrated success in managing patent litigation, disputes, oppositions, or post-grant proceedings
Company
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults.
201-500 employees
H1B Sponsorship
Mirum Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (2)
2023 (1)
2022 (1)
2021 (1)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$765.5MKey Investors
TCG CrossoverOberland CapitalNew Enterprise Associates
2025-12-19Post Ipo Equity· $68.5M
2025-12-08Post Ipo Equity· $200M
2023-04-12Post Ipo Equity· $275M
Leadership Team
Joanne Quan
Chief Medical Officer
Recent News
2026-01-03
2025-12-30
2025-12-19
Company data provided by crunchbase